Pretty sure I heard something along the lines of "the cancer (trials) as well" in his final statements that mostly centered on pushing forward with the NASH and HIV trials. It sounded like the cancer trials are second tier concerns behind the other two, but definitely on the radar. Limited cash and clinical progress made thus far are probably the reason I'd guess. The potential sooner as needed comment came across much louder than he spoke it! Made my ears prick up too.